Last reviewed · How we verify
NCT06346795
Class II Restorations With High-Filled Flowable Composites
NA trial testing High-filling flowable dental composite in Dental Caries in 60 participants. Not yet recruiting.
1 December 2024
Quick facts
| Lead sponsor | Selcuk University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 June 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- High-filling flowable dental composite
Conditions studied
- Dental Caries — all drugs for Dental Caries →
- Class II Dental Caries — all drugs for Class II Dental Caries →
Sponsor
Selcuk University
Who can join
Adults 18 to 50, any sex, with Dental Caries or Class II Dental Caries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the study, Class II restorations will be performed with G-aenial Universal Injectable (GC/ Tokyo, Japan), Grandio Flow (VOCO/ Germany), and Clearfil Majesty Flow (Kuraray/ Japan) composites will evaluated. Restorations will be assessed according to modified USPHS criteria in 1st week, 6th months, and 12th months from the placement date. The Chi-square test will used for statistical analysis of the difference between the groups, and the Cochran Q test will used for the significance of the difference between time-dependent changes within each group (p\<0.05).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06346795
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Caries
Currently open trials in the same condition.
- NCT06787261 — Involvement of Archaea in Carious Disease · NA · recruiting
- NCT06753669 — Mothers' Action Project for Child Health · NA · recruiting
- NCT07431463 — Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary T · NA · active not recruiting
- NCT07134114 — Occlusal Impact of Hall Crowns in Primary Molars · NA · recruiting
- NCT07181967 — SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children · NA · recruiting
Other Selcuk University trials
Trials by the same sponsor.
- NCT07402499 — Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain · not yet recruiting
- NCT07364591 — Immediate Effect of Kinesiotaping With Rounded Shoulder Posture in University Students · NA · not yet recruiting
- NCT07381244 — Validity, Reliability, and Clinical Correlates of Immersive Virtual Reality Adaptation of the Five Times Sit-to-stand Te · not yet recruiting
- NCT07373704 — Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis · not yet recruiting
- NCT07362368 — Virtual Reality-Based Five-Repetition Sit-to-Stand Test in Young Adults · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06346795 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Selcuk University
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06346795.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing